Clinical Trials Coverage
-
Moderna's initial vaccine results 'more than hoped for,' says UNC expert
Dr. Cindy Gay, who oversees the clinical trial of Moderna's coronavirus vaccine candidate at UNC-Chapel Hill, says she was the high initial efficacy rate shown by the drug "was more than we were hoping for." -
Triangle doctors share different experiences from vaccine trial
Drs. Nirmish and Sandy Shah both participated in the clinical trial for Moderna's potential coronavirus vaccine and had different experiences. -
'It means some hope that we are going to beat this thing'
A second experimental COVID-19 vaccine - this one from Moderna Inc. - yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase. -
2nd virus vaccine shows striking success in US tests
A second experimental COVID-19 vaccine -- this one from Moderna Inc. -- yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase. -
Duke infectious disease expert part of Pfizer vaccine trial
An infectious disease specialist at Duke University Hospital is one of the 44,000 people enrolled in Pfizer's clinical trials of a potential coronavirus vaccine. -
Some coronavirus vaccine trials paused, but those in NC still expanding
Thousands of North Carolina residents have stepped up to help test the safety and effectiveness of potential coronavirus vaccines, but the trials need even more participants. -
Coronavirus vaccine trials in NC showing promise so far
Thousands of North Carolina residents have stepped up to help test the safety and effectiveness of potential coronavirus vaccines, but the trials need even more participants. -
Experimental antibody treatment in clinical trials at Duke University similar to one President Trump received
After testing positive for coronavirus, President Trump was treated with an antibody treatment similar to one currently in trials at Duke University. -
Volunteer takes part in vaccine trial
It's the final countdown for researchers in the Triangle entering Phase 3 of COVID-19 vaccine trials. WRAL's Lora Lavigne speaks to someone who's committed to helping researchers fight the disease. -
Local woman shares excitement for participating in Phase 3 COVID-19 trials
It's the final countdown for researchers in the Triangle entering Phase 3 of COVID-19 vaccine trials. The goal is to have a vaccine ready by the end of the year. -
Pence praises speed, safety of coronavirus vaccine work
RESEARCH TRIANGLE PARK, N.C. – For the second time in three days, the Trump administration focused its attention on coronavirus […] -
Moderna plans local vaccine trial
WRAL Investigates is reporting on a local trial for a coronavirus vaccine. Joining WRAL News is Randall Kerr, senior investigative producer, to talk about that reporting and what you need to know to be able to volunteer for the trial. -
Soldier says neurofeedback study has improved his life
Soldiers at Fort Bragg are part of a clinical study that may change the way concussions are treated. -
Bragg study could help soldiers, others dealing with lingering concussion problems
Soldiers at Fort Bragg are part of a clinical study that may change the way concussions are treated. -
Report: Triangle is a leader in US for clinical trials with boost from university research
The Research Triangle area, long known as a tech hub in addition to a growing life science presence, is also a leader in medical clinical trials, according to a new report from TrialScout. Here are the details. -
SPONSORED
Struggling with an overactive bladder? New tech and treatment options could help
New classes of overactive bladder drugs have different mechanisms of action that may prove to be more effective for some patients than other anticholinergic activity drugs.